Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

"Microfluidics Market to Hit USD 105.13 Billion by 2033 with a CAGR of 12.22%"

globenewswire.com
ABT Abbott is mentioned as an industry leader advancing the IVD market by integrating microfluidics into their diagnostic platforms, suggesting positive impact from the growing microfluidics market. DHR Danaher is mentioned as an industry leader advancing the IVD market by integrating microfluidics into their diagnostic platforms, suggesting positive impact from the growing microfluidics market.

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Microfluidics Market Size, Share & Trends Analysis Report by Product (Microfluidic-based Devices, Microfluidic Components), Application (Medical, Non-Medical), Material (Silicon, Glass), Technology, and Region with Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global microfluidics market is on a rapid growth trajectory, with its size projected to soar from USD 41.92 billion in 2025 to USD 105.13 billion by 2033, marking a CAGR of 12.22% from 2026 to 2033. This robust expansion is largely driven by the extensive application of microfluidic devices across diverse research and diagnostic fields.

Advancements and Adoption of Microfluidics in Diagnostic Healthcare

The rising hospital costs and frequent patient readmissions have fueled the demand for dependable diagnostic tools. Simultaneously, prehospital and point-of-care (POC) solutions, such as at-home monitoring, help reduce hospital visits and inpatient stays. Industry leaders including Abbott, Roche, and Danaher are advancing the IVD market by integrating microfluidics into their diagnostic platforms, enabling earlier disease detection, quicker results, increased accuracy, and non-invasive sampling.

Microfluidics-enhanced POC testing solutions offer improved sensitivity, specificity, and quicker results, encouraging manufacturers to release microfluidics-based diagnostic kits for urgent testing needs. A case in point is LumiraDx, which obtained Emergency Use Authorization from India's CDSCO for its COVID-19 antigen test in October 2021, highlighting the significant role of microfluidics in pandemic response and public health diagnostics.

Global Microfluidics Market Report Segmentation

The report forecasts revenue growth and analyzes the latest trends in each sub-segment from 2021 to 2033, dividing the microfluidics market based on products, technology, materials, applications, and regions.

Product Outlook (USD Million, 2021-2033)

Technology Outlook (USD Million, 2021-2033)

Material Outlook (USD Million, 2021-2033)

Application Outlook (USD Million, 2021-2033)

Regional Outlook (USD Million, 2021-2033)

Why You Should Buy This Report

This report addresses:

Key Attributes:

Companies Featured

The companies profiled in this Microfluidics market report include:

For more information about this report visit https://www.researchandmarkets.com/r/d91x6c

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment